You are here

Data

Bivalent COVID-19 booster outperforms monovalent version --new study

A new Italian study finds that estimated relative vaccine effectiveness (rVE) was 49.3% for the bivalent (two-strain) booster and 26.9% for the monovalent (single-strain) booster, with protection lasting at least 4 months for the bivalent booster and waning fast for the monovalent version. The study appears in The Lancet Infectious Diseases.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COVID-19 vaccine affected reduced deaths in seniors with dementia

For the first time, researchers have calculated excess deaths among US dementia patients during the pandemic, and they found a reduction in excess mortality among long-term care residents after COVID-19 vaccines were made available. The study was published today in JAMA Neurology.

ALSO SEE: Alzheimer’s among seniors is most common in the eastern and southeastern US states

Problem, Solution, SitRep, or ?: 

Indications of a US COVID-19 uptick; more details of new vaccine rollout

Though COVID has held at very low levels late spring and into summer, some early indicators show signs of rising activity, according to the latest data from the Centers for Disease Control and Prevention (CDC).

In other developments, the CDC and the Department of Health and Human Services (HHS) fleshed out more details about when the updated COVID-19 vaccine will roll out and how federal health officials will ensure that uninsured and underinsured people can receive their doses.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Very high percentage of ambulance personnel reported stress during pandemic

In a study this week in PLOS One, researchers describe the mental health impact of the pandemic on ambulance personnel, showing through the findings of six studies that as many as 92.2% felt a psychological burden while working during COVID-19

...

 

.

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Data
howdy folks